Skip to main content
. 2023 Jan 31;67:10.29219/fnr.v67.9024. doi: 10.29219/fnr.v67.9024

Fig. 5.

Fig. 5

Molecular docking models of genistein with AKR1C3 and AKR1C3 inhibitors with AKR1C3. (a) The three-dimensional and two-dimensional structure of the interaction between genistein and AKR1C3. (b) The three-dimensional and two-dimensional structure of the interaction between AKR1C3 inhibitors and AKR1C3.